Lisa Wilson | IR |
Scott Tarriff | CEO |
Pete Meyers | CFO |
David Pernock | President and COO |
Randall Stanicky | RBC Capital Markets |
David Amsellem | Piper Sandler |
Brandon Folkes | Cantor Fitzgerald |
Good morning, and welcome to today's program. My name is Keith, and I'll be your conference operator. At this time, I'd like to welcome everyone to Eagle Pharmaceuticals' Second Quarter 2020 Earnings Results Conference Call. All lines have been placed on mute to prevent any background noise. After the speaker's remarks there will be a question-and-answer period.